Globus Medical (GMED) Tops Q1 EPS by 12c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Globus Medical (GMED) PT Raised to $73 at Stifel
May 5, 2021 9:36 AM EDTStifel analyst Mathew Blackman raised the price target on Globus Medical (NYSE: GMED) to $73.00 (from $60.00) while maintaining a Hold rating.
The analyst commented, "We expected GMED to post a strong 1Q, but the company's near-20% growth -- despite meaningful, early 1Q COVID... More
Globus Medical (GMED) PT Raised to $82 at Needham & Company
May 5, 2021 6:25 AM EDTNeedham & Company analyst Mike Matson raised the price target on Globus Medical (NYSE: GMED) to $82.00 (from $75.00) while maintaining a Buy rating.
The analyst commented, "GMED beat consensus revenue by 16% and EPS by 32% in 1Q21 driven by strong robotics implant pull-through, competitive rep hiring, new products,... More
